These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24011901)
1. An investigation of the role of soluble CD14 in hospitalized, sick horses. Silva A; Wagner B; McKenzie HC; Desrochers AM; Furr MO Vet Immunol Immunopathol; 2013 Oct; 155(4):264-9. PubMed ID: 24011901 [TBL] [Abstract][Full Text] [Related]
2. Comparison of lipopolysaccharides and soluble CD14 measurement between clinically endotoxaemic and nonendotoxaemic horses. Fogle J; Jacob M; Blikslager A; Edwards A; Wagner B; Dean K; Fogle C Equine Vet J; 2017 Mar; 49(2):155-159. PubMed ID: 27060869 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of plasma procalcitonin, soluble CD14, CCL2 and IL-10 after a sublethal infusion of lipopolysaccharide in horses. Bonelli F; Meucci V; Divers TJ; Wagner B; Intorre L; Sgorbini M Vet Immunol Immunopathol; 2017 Feb; 184():29-35. PubMed ID: 28166929 [TBL] [Abstract][Full Text] [Related]
4. Analysis of soluble CD14 and its use as a biomarker in neonatal foals with septicemia and horses with recurrent airway obstruction. Wagner B; Ainsworth DM; Freer H Vet Immunol Immunopathol; 2013 Sep; 155(1-2):124-8. PubMed ID: 23810420 [TBL] [Abstract][Full Text] [Related]
5. Functional analysis of recombinant bovine CD14. Wang Y; Zarlenga DS; Paape MJ; Dahl GE; Tomita GM Vet Res; 2003; 34(4):413-21. PubMed ID: 12911858 [TBL] [Abstract][Full Text] [Related]
6. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia. Barton MH; Bruce EH; Moore JN; Norton N; Anders B; Morris DD Am J Vet Res; 1998 Jun; 59(6):792-7. PubMed ID: 9622754 [TBL] [Abstract][Full Text] [Related]
7. Effects of hyperimmune equine plasma on clinical and cellular responses in a low-dose endotoxaemia model in horses. Forbes G; Church S; Savage CJ; Bailey SR Res Vet Sci; 2012 Feb; 92(1):40-4. PubMed ID: 21093001 [TBL] [Abstract][Full Text] [Related]
8. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin. Cargile JL; MacKay RJ; Dankert JR; Skelley L Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655 [TBL] [Abstract][Full Text] [Related]
9. Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli lipopolysaccharide. Lee JW; Paape MJ; Elsasser TH; Zhao X J Dairy Sci; 2003 Jul; 86(7):2382-9. PubMed ID: 12906056 [TBL] [Abstract][Full Text] [Related]
10. Disparate effects of LPS infusion and carbohydrate overload on inflammatory gene expression in equine laminae. Kwon S; Moore JN; Robertson TP; Hurley DJ; Wagner B; Vandenplas ML Vet Immunol Immunopathol; 2013 Sep; 155(1-2):1-8. PubMed ID: 23820116 [TBL] [Abstract][Full Text] [Related]
11. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes. Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661 [TBL] [Abstract][Full Text] [Related]
12. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide. Figueiredo MD; Salter CE; Hurley DJ; Moore JN Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485 [TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes. Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818 [TBL] [Abstract][Full Text] [Related]
14. Clinical and immunomodulating effects of ketamine in horses with experimental endotoxemia. Alcott CJ; Sponseller BA; Wong DM; Davis JL; Soliman AM; Wang C; Hsu W J Vet Intern Med; 2011; 25(4):934-43. PubMed ID: 21745244 [TBL] [Abstract][Full Text] [Related]
15. Effects of clopidogrel on horses with experimentally induced endotoxemia. Watts AE; Ness SL; Divers TJ; Fubini SL; Frye AH; Stokol T; Cummings KJ; Brooks MB Am J Vet Res; 2014 Aug; 75(8):760-9. PubMed ID: 25061708 [TBL] [Abstract][Full Text] [Related]
16. Endotoxemia during supraceliac aortic crossclamping is associated with suppression of the monocyte CD14 mechanism: possible role of transforming growth factor-beta1. Hafez HM; Berwanger CS; Lintott P; Delis K; Wolfe JH; Mansfield AO; Stansby G J Vasc Surg; 2000 Mar; 31(3):520-31. PubMed ID: 10709066 [TBL] [Abstract][Full Text] [Related]
17. Serum tumor necrosis factor alpha concentrations and clinical abnormalities in colostrum-fed and colostrum-deprived neonatal foals given endotoxin. Allen GK; Green EM; Robinson JA; Garner HE; Loch WE; Walsh DM Am J Vet Res; 1993 Sep; 54(9):1404-10. PubMed ID: 8239125 [TBL] [Abstract][Full Text] [Related]
18. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Bueno AC; Seahorn TL; Cornick-Seahorn J; Horohov DW; Moore RM Am J Vet Res; 1999 Aug; 60(8):969-76. PubMed ID: 10451207 [TBL] [Abstract][Full Text] [Related]
19. Expression of tlr4, md2 and cd14 in equine blood leukocytes during endotoxin infusion and in intestinal tissues from healthy horses. Fossum C; Hjertner B; Olofsson KM; Lindberg R; Ahooghalandari P; Camargo MM; Bröjer J; Edner A; Nostell K Vet Immunol Immunopathol; 2012 Dec; 150(3-4):141-8. PubMed ID: 23036528 [TBL] [Abstract][Full Text] [Related]
20. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Urbaschek R; McCuskey RS; Rudi V; Becker KP; Stickel F; Urbaschek B; Seitz HK Alcohol Clin Exp Res; 2001 Feb; 25(2):261-8. PubMed ID: 11236841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]